Tumor Treating Fields (EF-39)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tumor Treating Fields (EF-39), covering 2025-04-30 to 2025-04-30. Get the full timeline:
Most recent: Clinical Trial Update: EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]